Standard BioTools
LAB
LAB
81 hedge funds and large institutions have $217M invested in Standard BioTools in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 34 increasing their positions, 22 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less call options, than puts
Call options by funds: $283K | Put options by funds: $300K
28.09% less ownership
Funds ownership: 123.1% → 95.01% (-28%)
Holders
81
Holding in Top 10
1
Calls
$283K
Puts
$300K
Top Buyers
| 1 | +$2.73M | |
| 2 | +$2.37M | |
| 3 | +$1.99M | |
| 4 |
AC
Alexandria Capital
Arlington,
Virginia
|
+$1.11M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$817K |
Top Sellers
| 1 | -$3.81M | |
| 2 | -$2.76M | |
| 3 | -$957K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$538K |
| 5 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$421K |